Literature DB >> 27384838

Analysis of cutaneous tuberculosis cases reported from 2000 to 2013 at a university hospital in Rio de Janeiro.

Thales Pereira de Azevedo1, Maria Leide WanDelRey de Oliveira1.   

Abstract

INTRODUCTION: Tuberculosis (TB) is a serious public health problem; however, the cutaneous form remains rare.
METHODS: A retrospective analysis examined notified cutaneous tuberculosis (CTB) cases from 2000 to 2013 at the University Hospital Clementino Fraga Filho.
RESULTS: Twenty-six CTB cases were documented during this period. Erythema induratum of Bazin was the most common form, and 86.7% of such cases occurred in women (p=0.068). Only one patient was HIV positive.
CONCLUSIONS: This study confirms the rarity of CTB and highlights the need for multicenter studies in order to obtain an adequate number of cases for analysis.

Entities:  

Mesh:

Year:  2016        PMID: 27384838     DOI: 10.1590/0037-8682-0328-2015

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil.

Authors:  Danielle Mann; Flávia Marinho Sant'Anna; Carolina Arana Stanis Schmaltz; Dayvison Francis Saraiva Freitas; Valeria Cavalcanti Rolla; Solange Cesar Cavalcante; Maria Clara Gutierrez-Galhardo
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-07-26       Impact factor: 2.743

2.  Papulonecrotic tuberculid and Poncet disease: A case of multisystem delayed-type hypersensitivity in a patient with Mycobacterium tuberculosis infection.

Authors:  Melodi Javid Whitley; Jason E Stout; Atul Kapila; M Angelica Selim; Parisa Mansoori; Anne L Marano
Journal:  JAAD Case Rep       Date:  2019-08-29

3.  Erythema induratum of Bazin as an indicative manifestation of cavitary tuberculosis in an adolescent: a case report.

Authors:  Kun Yang; Tingying Li; Xiaomei Zhu; Yun Zou; Dongxian Liu
Journal:  BMC Infect Dis       Date:  2021-08-03       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.